Status: current, Defined. Date: 31-May 2023. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4819381000168116 | larotrectinib 20 mg / 1 mL oral liquid, 2 x 50 mL (medicinal product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4819391000168118 | larotrectinib 20 mg/mL oral liquid, 2 x 50 mL | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| larotrectinib 20 mg/mL oral liquid, 2 x 50 mL | Is a | larotrectinib 20 mg/mL oral liquid, 100 mL | true | Inferred relationship | Some | ||
| larotrectinib 20 mg/mL oral liquid, 2 x 50 mL | has MPUU | larotrectinib 20 mg/mL oral liquid | true | Inferred relationship | Some | 938543684 | |
| larotrectinib 20 mg/mL oral liquid, 2 x 50 mL | has subpack | larotrectinib 20 mg/mL oral liquid, 50 mL | true | Inferred relationship | Some | 695032237 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Vitrakvi 20 mg/mL oral liquid, 2 x 50 mL | Is a | True | larotrectinib 20 mg/mL oral liquid, 2 x 50 mL | Inferred relationship | Some |
Reference Sets
Medicinal product pack reference set
FHIR